PharmaResearch (Pharmaceuticals) Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
470
- Stock Symbol
-
214450
- Investments
-
6
- Share Price
-
$188.10
- (As of Friday Closing)
PharmaResearch (Pharmaceuticals) General Information
Description
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.
Contact Information
Website
www.pharmaresearch.co.krCorporate Office
- 77-19, Gwahakdanji-ro
- Gangneung, Gangwon 25452
- South Korea
Corporate Office
- 77-19, Gwahakdanji-ro
- Gangneung, Gangwon 25452
- South Korea
PharmaResearch (Pharmaceuticals) Timeline
PharmaResearch (Pharmaceuticals) Stock Performance
As of 13-Nov-2026, PharmaResearch (Pharmaceuticals)’s stock price is $188.10. Its current market cap is $1.95B with 10.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $188.10 | $185.15 | $153.50 - $391.93 | $1.95B | 10.4M | 105K | $12.32 |
PharmaResearch (Pharmaceuticals) Financials Summary
As of 30-Jun-2026, PharmaResearch (Pharmaceuticals) has a trailing 12-month revenue of $416M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,197,001 | 2,703,373 | 1,737,883 | 763,439 |
| Revenue | 415,900 | 376,836 | 256,600 | 199,634 |
| EBITDA | 183,392 | 159,148 | 90,820 | 82,821 |
| Net Income | 127,951 | 116,026 | 67,459 | 58,550 |
| Total Assets | 717,543 | 724,918 | 580,935 | 415,372 |
| Total Debt | 8,900 | 7,288 | 9,598 | 26,018 |
PharmaResearch (Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PharmaResearch (Pharmaceuticals) Signals
PharmaResearch (Pharmaceuticals) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PharmaResearch (Pharmaceuticals) Investments & Acquisitions (6)
PharmaResearch (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Cosmetic Group USA. The deal was made on 30-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cosmetic Group USA | 30-Jun-2026 | Merger/Acquisition | BPO/Outsource Services | ||
| Connext | 16-Mar-2026 | Later Stage VC | Biotechnology | ||
| TURINGBIO | 10-Jul-2024 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Promore Pharma | 06-Jul-2017 | IPO | Drug Discovery | ||
| DrJSkinClinic | 13-Jun-2016 | Merger/Acquisition | Personal Products |
PharmaResearch (Pharmaceuticals) ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.75 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
PharmaResearch (Pharmaceuticals) Exits (2)
PharmaResearch (Pharmaceuticals)’s most recent exit was on 06-Jul-2017 from Promore Pharma. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Promore Pharma | 06-Jul-2017 | Completed |
|
||
| Promore Pharma | Early Stage VC | Completed |
|
PharmaResearch (Pharmaceuticals) Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| TURINGBIO | Seongnam, South Korea | 2020 | |
| DrJSkinClinic | Cerritos, CA | 2000 |
PharmaResearch (Pharmaceuticals) FAQs
-
When was PharmaResearch (Pharmaceuticals) founded?
PharmaResearch (Pharmaceuticals) was founded in 1993.
-
Where is PharmaResearch (Pharmaceuticals) headquartered?
PharmaResearch (Pharmaceuticals) is headquartered in Gangneung, South Korea.
-
What is the size of PharmaResearch (Pharmaceuticals)?
PharmaResearch (Pharmaceuticals) has 470 total employees.
-
What industry is PharmaResearch (Pharmaceuticals) in?
PharmaResearch (Pharmaceuticals)’s primary industry is Pharmaceuticals.
-
Is PharmaResearch (Pharmaceuticals) a private or public company?
PharmaResearch (Pharmaceuticals) is a Public company.
-
What is PharmaResearch (Pharmaceuticals)’s stock symbol?
The ticker symbol for PharmaResearch (Pharmaceuticals) is 214450.
-
What is the current stock price of PharmaResearch (Pharmaceuticals)?
As of 13-Nov-2026 the stock price of PharmaResearch (Pharmaceuticals) is $188.10.
-
What is the current market cap of PharmaResearch (Pharmaceuticals)?
The current market capitalization of PharmaResearch (Pharmaceuticals) is $1.95B.
-
What is PharmaResearch (Pharmaceuticals)’s current revenue?
The trailing twelve month revenue for PharmaResearch (Pharmaceuticals) is $416M.
-
What is PharmaResearch (Pharmaceuticals)’s annual earnings per share (EPS)?
PharmaResearch (Pharmaceuticals)’s EPS for 12 months was $12.32.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process